About this program
EnrollDate
October 2, 2023 -
Occasions
Learn at your own pace (4 hours)
Place
Online
Language
English
Price
0 CAD + tax
Facilitators
Course description
In this introductory course, you’ll gain an understanding of the various psychedelic medicines and how they can be used to treat conditions like depression, anxiety, post-traumatic stress, substance use disorders, and others.
This course invites you to explore the world of psychedelics, their effects, their harm potential, and their potential as therapeutic tools. We will embark on a journey through time, exploring the impact of The Controlled Drugs and Substances Act in Canada and The Controlled Substances Act in the United States on psychedelic research and drug policy. This program will also explore the nuances of cultural safety and humility within the context of psychedelic-assisted therapy, recognizing the significance of inclusive and respectful practices.
This free course is open to both regulated and non-regulated providers, as well as empowered individuals looking to better understand psychedelic medicines and their healing potential.
If you’re interested in expanding your skills as a health professional, consider also registering for the Numinus certification pathway in psychedelic-assisted therapy.
Time Commitments
This course includes 4 hours of online content and is offered in English. Please see below for more information.
Prerequisites
There are no prerequisites for these courses.
Content Overview
Please use the arrows below to learn more about what will be taught in each module.
Learning Outcomes
• Define psychedelic within the context of the psychedelic journey.
• Categorize psychedelics according to their shared properties, effects, and primary mechanism of action.
• List the psychoactive compound in each psychedelic.
• Compare the harm potential of common recreational substances.
Learning Outcomes
• Compare the outcomes of psychedelic-assisted therapy and traditional psychopharmacological therapy.
• Describe the differences between ketamine therapy and ketamine-assisted therapy.
• Discuss the need for psychedelic integration therapy.
• Explain the overarching psychobiological mechanisms of action of psychedelic-assisted therapy.
Learning Outcomes
• Describe the potential for risk of using psychedelic medicines inside and outside of a clinical setting.
• Explain set and setting within the context of psychedelic medicines.
• Discuss the stigma around psychedelics and its impact on marginalized communities.
• List strategies for harm reduction in psychedelic-assisted therapy.
• Discuss important safety measures for psychedelic-assisted therapy.
Learning Outcomes
• Explain the impact that The Controlled Drug and Substances Act (Canada) and The Controlled Substances Act (United States) had and continue to have on psychedelic research and drug policy.
• Discuss cultural safety and humility in the context of psychedelic-assisted therapy.
• Outline key historical events that have contributed to the development of psychedelic-assisted therapy.
• List key studies that have investigated the outcomes of psychedelic-assisted therapy.
Learning Outcomes
After the course, you’ll be able to:
-
Categorize psychedelics according to their shared properties, effects, and primary mechanism of action.
-
Compare the outcomes of psychedelic-assisted therapy and traditional psychopharmacological therapy.
-
Outline key historical events that have contributed to the development of psychedelic-assisted therapy.
-
List key studies that have investigated the outcomes of psychedelic-assisted therapy.
-
Describe the potential for risk of using psychedelic medicines inside and outside of a clinical setting.
Disclaimer
The continuing professional development program in no way promotes, condones, or facilitates illegal activity, and is strictly for educational and harm reduction purposes only. Please be aware that certain psychedelic substances still remain illegal in many jurisdictions, including Canada. This program and the contents of this website do not constitute medical advice and are not a substitute for professional medical advice and treatment.
FAQs
No, there are no prerequisites.
Yes – for 4 hours
No – the Introduction to Psychedelics course is entirely asynchronous and can be completed on your own schedule.
Yes absolutely. This course is open to anyone looking to learn more about the evidence and healing potential of psychedelic medicines.
Yes – absolutely
Yes, this course is recognized by the following organizations for continuing education credit.
Canadian Psychological Association
4 credit hours
Canadian Counselling and Psychotherapy Association
4 credit hours
L’Ordre des psychologues du Québec
4 credit hours
National Board for Certified Counselors
Credit hours TBD
Numinus Wellness has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7360. Programs that do not qualify for NBCC credit are clearly identified. Numinus Wellness is solely responsible for all aspects of the programs.
We’re happy to help. Send us an e-mail at training@numinus.com
